This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Acuity Brands (AYI) Looks Good: Stock Adds 5.2% in Session
by Zacks Equity Research
Acuity Brands (AYI) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Innovative Luminaries Aid Acuity Brands Amid Margin Woes
by Zacks Equity Research
Acuity Brands' (AYI) innovative lighting solutions and prudent cost management are set to drive overall growth despite COVID-19 impacts and unfavorable pricing.
The Zacks Analyst Blog Highlights: Workhorse Group, Veritone, Microvision, Energy Focus and Wayfair
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Workhorse Group, Veritone, Microvision, Energy Focus and Wayfair
Acuity Brands (AYI) Q3 Earnings Top Estimates, Stock Up
by Zacks Equity Research
Acuity Brands (AYI) posts impressive fiscal third-quarter 2020 results on the back of go-to-market channels, product portfolio and supply chain.
Wall Street Sees Best Quarter After 1998: 5 Top Winners
by Tirthankar Chakraborty
Recovering from a drop of 20% in Q1, the broader S&P 500 rallied around 20% in Q2, the biggest quarterly gain in more than two decades.
Energy Focus (EFOI) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Energy Focus (EFOI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
5 Growth Stocks to Buy as Market Soars on Positive Job Data
by Zacks Equity Research
Stocks rally on positive job data, making growth stocks interesting investment picks.
Orion Energy (OESX) Q4 Earnings Miss Estimates, Improve Y/Y
by Zacks Equity Research
Orion Energy Systems (OESX) reports disappointing results in fourth-quarter fiscal 2020 owing to COVID-19 impacts.
The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Aileron Therapeutics, Energy Focus, MicroVision, Mersana Therapeutics and CymaBay Therapeutics
Acuity Brands and Ushio Partner for Care222 UV Light Module
by Zacks Equity Research
Acuity Brands (AYI) plans to incorporate Care222 UV disinfection module in its leading lighting fixtures to reduce pathogens on indoor surfaces.
Orion Energy (OESX) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
New product introductions, turnkey services and strong customer-centric approach are likely to help Orion Energy Systems (OESX) to post higher year-over-year fiscal fourth-quarter earnings.
5 Top Stocks Up 100%+ in May With More Room to Run
by Tirthankar Chakraborty
Reopening of the economy, vaccine hopes and stimulus measures helped Wall Street climb north in May and squash the old adage "sell in May and go away."
Top Ranked Momentum Stocks to Buy for May 27th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 27th
Energy Focus (EFOI) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Energy Focus (EFOI) delivered earnings and revenue surprises of 42.86% and 9.34%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Energy Focus (EFOI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Energy Focus (EFOI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Energy Focus (EFOI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Energy Focus (EFOI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acuity Brands Benefits From Innovation Amid Soft Demand
by Zacks Equity Research
Acuity Brands's (AYI) innovative lighting solutions and acquisitions will drive overall growth. However, softness in the industry and higher costs raise concerns.
Acuity Brands' (AYI) Q1 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Acuity Brands' (AYI) fiscal first-quarter 2020 results hurt by macro-economic factors and lower volumes.
Here's Why Investors Should Steer Clear of Acuity Brands
by Zacks Equity Research
Weak industry prospects, and higher costs and expenses are hurting Acuity Brands' (AYI) performance.
Acuity Brands Unveils Versatile & Compact Modulus System
by Zacks Equity Research
Acuity Brands (AYI) launches innovative Modulus system to elevate luminaire design and reduce ownership cost.
Acuity Brands & CIRCADIAN to Commercialize Zirc Technology
by Zacks Equity Research
Acuity Brands (AYI) adds another innovative lighting control solution to its portfolio via its partnership with CIRCADIAN ZircLight.
Acuity Brands Boosts Product Offering With LocusLabs Buyout
by Zacks Equity Research
Acuity Brands (AYI) acquires LocusLabs to boost indoor navigation experience.
Acuity Brands (AYI) Unveils Smart Home Automation Juno AI
by Zacks Equity Research
Acuity Brands (AYI) launches innovative portfolio of downlights to simplify smart home automation.
Energy Focus (EFOI) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Energy Focus (EFOI) delivered earnings and revenue surprises of 46.67% and -7.17%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Energy Focus (EFOI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Energy Focus (EFOI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.